 |
|
Chemical can reproduce complications for some patients
May 01, 2009Medical science took a giant leap forward with the development of techniques that, at least temporarily, perform the function of vital organs. These processes, including the use of the heart-lung machine and renal dialysis, require the blood to be circulated through tubing outside the body and are hence known as extracorporeal circulation (EC) and have provided critical life support for millions of patients. Yet EC is not without its own risks. Among them are unique morbidities such as depressed cardiac output, abnormal heart rhythm, and swelling of the major organs. Studies have been conducted for decades to determine how these effects can be reduced and eliminated. In a new study conducted by a Johns Hopkins team, the researchers examined whether a solvent used in the production of intravenous (IV) bags and EC circuits could play a role. Their results indicate that 1) the solvent cyclohexanone (CHX) can leach into IV and EC fluids, and 2) CHX administered in controlled doses in an animal model replicates the cardiovascular and lung morbidities that are seen in patients during and after EC treatment. The study sheds new light on the potential causes of EC-related disorders.
The study was conducted by Caitlin S. Thompson-Torgerson and Lakshmi Santhanam, Department of Biomedical Engineering; Hunter C. Champion, Department of Medicine (Division of Cardiology); Z. Leah Harris, Department of Anesthesiology and Critical Care Medicine; and Artin A. Shoukas, Departments of Biomedical Engineering, Anesthesiology and Critical Care Medicine, and Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD. The study, entitled Cyclohexanone Contamination From Extracorporeal Circuits Impairs Cardiovascular Function, is published in the online edition of the American Journal of Physiology-Heart and Circulatory Physiology.
The Study
Cyclohexanone (CHX) is an organic solvent widely used in the production of polyvinyl chloride (PVC) medical devices, including IV fluid bags and EC circuits. CHX can migrate from PVC tubing and connections into fluids that come in contact with PVC. CHX can leach from PVC bags and IV tubing into intravenous fluids in sufficient concentrations to be detected in neonatal urine samples. Therefore, it is possible that patients on EC support are at risk for CHX exposure, given that their full blood volumes circulate continuously through CHX-treated tubing and are frequently augmented with IV fluids.
While the toxicity of PVC and CHX has been previously documented in animal models, no studies have made comparisons to clinical intravenous CHX exposure. Accordingly, the researchers developed a series of experiments to establish current values for CHX contamination in crystalloid fluid from IV bags and EC circuits, and to test the hypothesis that a clinically observed dose of CHX could reproduce the vital organ dysfunction that can accompany EC support/treatment.
Methodology
To quantify the degree of CHX contamination of fluids, researchers from Johns Hopkins Medical Institutions collected saline samples from IV bags and other commercially available bags, bypass circuits, ECMO circuits and dialysis circuits. CHX levels were measured using gas chromotography-mass spectrometry (GCMS). These results were used to determine a clinically relevant intravenous dose of CHX. A dose of CHX was then calculated and given intravenously to adult male rats. Saline stored in and administered from glass bottles was given to a control group. Dosing calculations were designed so that they approximated a conservative adult EC patient exposure to CHX, including the abrupt nature of the exposure that EC patients undergo when they are connect to circuit tubing.
There were three protocols used in the study:
Protocol 1 was designed to measure several aspects cardiovascular function. Animals were anesthetized, tracheotomized, ventilated using a rodent ventilator, and then instrumented so that the researchers could measure cardiac output, heart rate, stroke volume, blood pressure, and heart contractile function. Measurements were made at baseline and again 60 minutes after infusion of CHX or saline.
Protocol 2 was designed to measure cardiovascular autonomic function, including how well the nervous system was able to maintain blood pressure in the face of a challenge. After the animals were anesthetized and instrumented to measure blood pressure, both carotid arteries were occluded (obstructed), which stimulates a reflex called the baroreflex that controls blood pressure. After this baseline assessment of reflex function, CHX or saline was infused and allowed to circulate for 30-40 minutes, followed by another round of occlusions. A subsequent identical infusion was given and allowed to circulate for an additional 30-40 minutes, followed by a final round of occlusions.
Protocol 3 was designed to measure edema formation, or the volume of water that has been retained in major organs of the body. After the animals were anesthetized, each rat received an infusion of either CHX or saline, which was allowed to circulate through the body for 2 hours. After 2 hours, the animal was euthanized, and the liver, kidneys, lungs, and skin were harvested, weighed, dried at 100°C, and weighed again to quantify the fluid content in each organ at the time of death. Results In protocol 1, all baseline values were similar between saline and CHX groups. In the 60 minutes following saline infusion, none of the variables changed significantly from baseline. The CHX infusion, however, induced significant adverse changes in all cardiovascular variables. Both stroke volume and heart rates values were significantly depressed after one hour of CHX, resulting in a significant decline in cardiac output in the CHX rats. Stroke volume, in turn, was depressed because the inherent contractile ability of the heart was significantly reduced. CHX exposure also resulted in high blood pressure in the lung vessels, a dangerous condition known as pulmonary hypertension.
In protocol 2, prior to infusions, both saline and CHX groups exhibited similar significant baroreflex pressor responses to carotid occlusion. After both 1st and 2nd saline infusions, the pressor response in the control group did not differ significantly from baseline. However, in the CHX group, the pressor response was blunted after the first infusion and was undetectable after the 2nd CHX infusion. There are a myriad of neurological complications that develop in patients who undergo EC support. The relative contributions of the underlying disease vs. the treatment are often difficult to discern. Moreover, the potential contribution of CHX to the evolution of these complications has not been investigated.
In protocol 3, the wet/dry ratio of organ weights served as an index of tissue fluid retention and, thus, edema formation. The ratios for all individual organs within each treatment group were pooled to create an overall index of edema formation. The pooled ratio for the CHX group was significantly higher than the saline group.
Conclusions
According to Dr. Thompson-Torgerson, lead author on the paper, and Dr. Shoukas, the senior researcher on the study, "The data from this study provide a current estimate of CHX contamination in most commercially available IV bags and EC circuits. The data allowed us to determine a clinically relevant CHX exposure. A similar level of exposure in animals resulted in cardiovascular morbidities analogous to those observed following clinical EC treatment. This supports our hypothesis that CHX may contribute to EC-related cardiovascular insufficiency. However, we would never tell patients to decline EC treatment if they need it. On the contrary, EC technologies are life-saving medical advances, and the benefits of EC therapy still far outweigh the risks of the associated morbidities. If a patient and doctor have decided that EC treatment is the best course, then stick to that plan. As scientists, we are simply trying to understand how the side effects are triggered and what the best method will be to mitigate, and ultimately remedy, these morbidities. "
American Physiological Society
Cyclohexanone (CHX) is an organic solvent widely used in the production of polyvinyl chloride (PVC) medical devices, including IV fluid bags and EC circuits. CHX can migrate from PVC tubing and connections into fluids that come in contact with PVC. CHX can leach from PVC bags and IV tubing into intravenous fluids in sufficient concentrations to be detected in neonatal urine samples. Therefore, it is possible that patients on EC support are at risk for CHX exposure, given that their full blood volumes circulate continuously through CHX-treated tubing and are frequently augmented with IV fluids.
While the toxicity of PVC and CHX has been previously documented in animal models, no studies have made comparisons to clinical intravenous CHX exposure. Accordingly, the researchers developed a series of experiments to establish current values for CHX contamination in crystalloid fluid from IV bags and EC circuits, and to test the hypothesis that a clinically observed dose of CHX could reproduce the vital organ dysfunction that can accompany EC support/treatment.
Methodology
To quantify the degree of CHX contamination of fluids, researchers from Johns Hopkins Medical Institutions collected saline samples from IV bags and other commercially available bags, bypass circuits, ECMO circuits and dialysis circuits. CHX levels were measured using gas chromotography-mass spectrometry (GCMS). These results were used to determine a clinically relevant intravenous dose of CHX. A dose of CHX was then calculated and given intravenously to adult male rats. Saline stored in and administered from glass bottles was given to a control group. Dosing calculations were designed so that they approximated a conservative adult EC patient exposure to CHX, including the abrupt nature of the exposure that EC patients undergo when they are connect to circuit tubing.
There were three protocols used in the study:
Protocol 1 was designed to measure several aspects cardiovascular function. Animals were anesthetized, tracheotomized, ventilated using a rodent ventilator, and then instrumented so that the researchers could measure cardiac output, heart rate, stroke volume, blood pressure, and heart contractile function. Measurements were made at baseline and again 60 minutes after infusion of CHX or saline.
Protocol 2 was designed to measure cardiovascular autonomic function, including how well the nervous system was able to maintain blood pressure in the face of a challenge. After the animals were anesthetized and instrumented to measure blood pressure, both carotid arteries were occluded (obstructed), which stimulates a reflex called the baroreflex that controls blood pressure. After this baseline assessment of reflex function, CHX or saline was infused and allowed to circulate for 30-40 minutes, followed by another round of occlusions. A subsequent identical infusion was given and allowed to circulate for an additional 30-40 minutes, followed by a final round of occlusions.
Protocol 3 was designed to measure edema formation, or the volume of water that has been retained in major organs of the body. After the animals were anesthetized, each rat received an infusion of either CHX or saline, which was allowed to circulate through the body for 2 hours. After 2 hours, the animal was euthanized, and the liver, kidneys, lungs, and skin were harvested, weighed, dried at 100°C, and weighed again to quantify the fluid content in each organ at the time of death. Results In protocol 1, all baseline values were similar between saline and CHX groups. In the 60 minutes following saline infusion, none of the variables changed significantly from baseline. The CHX infusion, however, induced significant adverse changes in all cardiovascular variables. Both stroke volume and heart rates values were significantly depressed after one hour of CHX, resulting in a significant decline in cardiac output in the CHX rats. Stroke volume, in turn, was depressed because the inherent contractile ability of the heart was significantly reduced. CHX exposure also resulted in high blood pressure in the lung vessels, a dangerous condition known as pulmonary hypertension.
In protocol 2, prior to infusions, both saline and CHX groups exhibited similar significant baroreflex pressor responses to carotid occlusion. After both 1st and 2nd saline infusions, the pressor response in the control group did not differ significantly from baseline. However, in the CHX group, the pressor response was blunted after the first infusion and was undetectable after the 2nd CHX infusion. There are a myriad of neurological complications that develop in patients who undergo EC support. The relative contributions of the underlying disease vs. the treatment are often difficult to discern. Moreover, the potential contribution of CHX to the evolution of these complications has not been investigated.
In protocol 3, the wet/dry ratio of organ weights served as an index of tissue fluid retention and, thus, edema formation. The ratios for all individual organs within each treatment group were pooled to create an overall index of edema formation. The pooled ratio for the CHX group was significantly higher than the saline group.
Conclusions
According to Dr. Thompson-Torgerson, lead author on the paper, and Dr. Shoukas, the senior researcher on the study, "The data from this study provide a current estimate of CHX contamination in most commercially available IV bags and EC circuits. The data allowed us to determine a clinically relevant CHX exposure. A similar level of exposure in animals resulted in cardiovascular morbidities analogous to those observed following clinical EC treatment. This supports our hypothesis that CHX may contribute to EC-related cardiovascular insufficiency. However, we would never tell patients to decline EC treatment if they need it. On the contrary, EC technologies are life-saving medical advances, and the benefits of EC therapy still far outweigh the risks of the associated morbidities. If a patient and doctor have decided that EC treatment is the best course, then stick to that plan. As scientists, we are simply trying to understand how the side effects are triggered and what the best method will be to mitigate, and ultimately remedy, these morbidities. "
American Physiological Society
Cardiovascular Current Events and Cardiovascular News RSSKey player identified in cascade that leads to hypertension-related kidney damage
A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both.
Study suggests dentists can identify patients at risk for fatal cardiovascular event
A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation.
Physical education key to improving health in low-income adolescents
School-based physical education plays a key role in curbing obesity and improving fitness among adolescents from low-income communities, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.
Breeding better broccoli
Carotenoids-fat-soluble plant compounds found in some vegetables-are essential to the human diet and reportedly offer important health benefits to consumers.
Postmenopausal women with higher testosterone levels
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels.
Longer toes, unique ankle structure aid sprinters
Longer toes and a unique ankle structure provide sprinters with the burst of acceleration that separates them from other runners, according to biomechanists.
New methods found useful for diagnosing myocarditis
Myocarditis is an important, and often unrecognized cause of dilated cardiomyopathy (DCM). Several new diagnostic methods, such as cardiac magnetic resonance imaging (MRI), are useful for diagnosing myocarditis, according to a study published in the November 2009 issue of Mayo Clinic Proceedings.
Researchers identify the three killer indicators that are even worse than high cholesterol
Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality.
UI study reveals second pathway to feeling your heartbeat
A new study suggests that the inner sense of our cardiovascular state, our "interoceptive awareness" of the heart pounding, relies on two independent pathways, contrary to what had been asserted by prominent researchers.
Help your kidneys: Pass on salt and diet soda
Individuals who consume a diet high in sodium or artificially sweetened drinks are more likely to experience a decline in kidney function, according to two papers being presented at the American Society of Nephrology's annual meeting in San Diego, California.
More Cardiovascular Current Events and Cardiovascular News Articles
 |
Cardiovascular Care Made Incredibly Easy! (Incredibly Easy! Series) by Diane Labus (Editor) Cardiovascular Care Made Incredibly Easy! Second Edition is a handy reference book in the award-winning Incredibly Easy style--perfect for those entering or needing a refresher in cardiovascular nursing care. Because cardiovascular care is one of the most demanding and complex areas of nursing practice, practicing nurses and nursing students can benefit most from a resource that is easy to read and understand. This one-of-a-kind book brings together the broad base of knowledge that nurses need to be confident in their cardiovascular care, including fundamentals, such as cardiovascular anatomy and physiology; assessment; diagnostic testing; hemodynamic monitoring; electrocardiogram performance and interpretation; medications; synchronized cardioversion; care of patients with IABP... |
 |
Manual of Cardiovascular Medicine by Brian P Griffin (Editor), Eric J Topol (Editor), Deepu Nair (Editor), Kellan Ashley (Editor) Thoroughly revised and updated, this pocket-sized manual is an adaptation of Topol's Textbook of Cardiovascular Medicine, Third Edition. The third edition of this best-selling manual follows the same structure as previous editions, using an outline format with key words and phrases highlighted in bold. The concise text provides easy access to the information needed to treat patients with cardiovascular disease and is appropriate for residents, fellows, practicing cardiologists, and nurse-practitioners. The content reflects Topol's text and Brian Griffin adds suggested reading at the end of each chapter. This latest revision presents updated clinical information and has eight new chapters, including obesity and metabolic syndrome, women and heart disease, and heart failure... |
 |
Cardiovascular Physiology (LANGE Physiology Series) by David Mohrman (Author) CLEAR, CONCISE, AND UP-TO-DATE Here is a direct, highly readable way for students to gain a fundamental knowledge and basic understanding of cardiovascular physiology. Experienced practitioners will find this versatile reference to be the perfect refresher course and a convenient way to stay up-to-date on the latest research and developments in this ever-changing field. THE NUMBER 1 CHOICE FOR CARDIOVASCULAR PHYSIOLOGY Provides a short, well-mapped path to mastery of concepts and functions of cardiovascular physiology Clarifies the details of physiologic mechanisms and their role in pathologic states Links cardiovascular physiology to diagnosis and treatment Summarizes key concepts at the end of each chapter, with pointers to the source... |
 |
Extreme Health's Heart Supplement Formula, Oral Chelation/Age-Less set for Cardiovascular Health, 2 bottles -(AM bottle, 60 caplets, PM bottle 60 caps by Extreme Health Dietary supplement. Promotes healthy blood pressure and cholesterol (levels already within a normal range). Plus increases blood flow. Cleansing of arterial walls. Doctor recommended for years. The set is never sold separately as they are a complete system. Both bottles are free of wheat, rye, oats, barley, gluten, sugar, wax, yeast, sulfates, chlorides, phosphates, egg, casein, preservatives or any other milk derivatives. Used by DOCTORS for over 8 years, including Doctors who specialize in intravenous chelation (most other oral chelation/heart supplement brands are not effective enough for doctors to offer in their practice) Extreme has 8 years of clinical studies by doctors. EDTA as a single ingredient may be dangerous, Extreme Health's formula includes EDTA plus 16 other Chelators,... |
 |
The Cardiovascular System at a Glance by Philip I. Aaronson (Author), Jeremy P. T. Ward (Author) This concise and accessible systems-based text provides an integrated overview which considers both the basic sciences and clinical applications of the cardiovascular system. A general introduction to the cardiovascular system is followed by anatomy and histology, blood and body fluids, biochemistry and excitation–contraction coupling, form and function, integration and regulation, and pathology and therapeutics. The Cardiovascular System at a Glance is a perfect introduction and revision aid to understanding the heart and circulation and now also features: An extended section of self-assessment clinical cases to aid revision and illustrate clinical relevance Up-to-date information on pharmacology of the cardiovascular system Expanded material on history and examination... |
 |
Cardiovascular Physiology Concepts by Richard E Klabunde (Author) This uniquely readable, compact, and concise monograph lays a foundation of knowledge of the underlying concepts of normal cardiovascular function. Students welcome the book's broad overview as a practical partner or alternative to a more mechanistically oriented approach or an encyclopedic physiology text. Especially clear explanations, ample illustrations, a helpful glossary of terms, tutorials, and chapter-opening learning objectives provide superb guidance for self-directed learning and help fill the gap in many of today's abbreviated physiology blocks. A focus on well-established cardiovascular principles reflects recent, widely accepted cardiovascular research. The supplemental CD-ROM is an interactive, dynamically linked version of the book, which is organized by normal... |
 |
Journal of Cardiovascular Nursing by Lippincott Williams & Wilkins Official journal of the Preventive Cardiovascular Nurses Association, The Journal of Cardiovascular Nursing is one of the leading journals for advanced practice nurses in cardiovascular care, providing thorough coverage of timely topics and practical information. |
 |
RESOURCES Canine Cardiovascular Support (Tablets 120) by Resources The Cardiovascular formula is a well-rounded nutritional supplement targeting the entire cardiovascular system including the essential nutrients vitamin E, Magnesium, and Selenium supported by strong antioxidants including Coenzyme Q-10. The amino acids L-carnitine and L-taurine assist in transporting oxygen to the cells allowing the heart to use energy more efficiently. Suggested Use: Up to 50lbs...1 tablet twice daily, 50 to 100lbs...2 tablets twice daily, Over 100lbs...3 tablets twice daily Tablets Tablets may be given orally or crumbled and mixed with moist food. Responses to natural dietary supplements may vary by animal. One tablet guaranteed to contain: Magnesium...26mg, Selenium...26mcg, Vitamin E (d-alpha tocopherol)...53 I.U., Zizzifus...210mg, Hawthorn...158mg,... |
 |
RN Expert Guides: Cardiovascular Care by Springhouse (Editor) RN Expert Guides are presented in the quick-reference, easy-to-follow style that exemplifies all the RN Expert Guides. Also, as with other RN Expert Guides, explanations are clarified and enhanced by abundant illustrations and tables. This RN Expert Guide covers principles and practices of cardiovascular care, along with anatomy and physiology, assessment, diagnostic test results, and specific treatments. These chapters are followed by chapters on cardiovascular disorders, and emergencies and complications. The book is further supplemented through the use of eye-catching icons and by a thorough list of important selected references. |
 |
Ecological Formulas/Cardiovascular Research Melatone 3mg 60c by ECOLOGICAL FORMULAS - CARDIOVASCULAR RESEARCH Melatone is a scientifically designed supplement. Contains a pure, synthetic source of melatonin, naturally present in the pineal gland |
| © 2009 BrightSurf.com |